(19)
(11) EP 1 892 012 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
10.10.2012 Bulletin 2012/41

(45) Mention of the grant of the patent:
05.09.2012 Bulletin 2012/36

(21) Application number: 07118531.8

(22) Date of filing: 02.07.2003
(51) International Patent Classification (IPC): 
A61N 2/00(2006.01)

(54)

Devices for luminal and sphincter augmentation

Vorrichtungen für Lumen- und Schließmuskelaugmentation

Dispositifs pour augmenter la membrane luminale et le sphincter

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

(30) Priority: 02.07.2002 US 393624 P

(43) Date of publication of application:
27.02.2008 Bulletin 2008/09

(62) Application number of the earlier application in accordance with Art. 76 EPC:
03742434.8 / 1517726

(73) Proprietor: Torax Medical, Inc.
Shoreview, Minnesota 55126 (US)

(72) Inventors:
  • Deem, Mark
    Mountain View, CA 94041 (US)
  • Gifford, Hanson, S.
    Woodside, CA 94062 (US)
  • Andreas, Bernard
    Redwood City, CA 94062 (US)
  • Chew, Sunmi
    San Jose, CA 95126 (US)
  • French, Ron
    Santa Clara, CA 95050 (US)
  • Sutton, Doug
    Pacifica, CA 94044 (US)

(74) Representative: Clark, Jane Anne et al
Mathys & Squire LLP 120 Holborn
London EC1N 2SQ
London EC1N 2SQ (GB)


(56) References cited: : 
WO-A-02/11696
US-A- 5 176 618
 DE-A1- 3 011 742
US-A- 5 509 888
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).